We are live on ! Find out more
PA

PharVision Advisers Portfolio holdings

AUM $9.86M
1-Year Est. Return 9.93%
This Fund
S&P 500
This Quarter Est. Return
-4.09%
1 Year Est. Return
+9.93%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$72.1M
AUM Growth
-$46.2M
Cap. Flow
-$42.5M
Cap. Flow %
-59.01%
Top 10 Hldgs %
8.49%
Holding
545
New
165
Increased
47
Reduced
47
Closed
286

Sector Composition

Rank Sector Weight
1 Technology 19.94%
2 Financials 19.07%
3 Industrials 13.76%
4 Consumer Discretionary 12.4%
5 Real Estate 11.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIRC icon
526
Virco
VIRC
$94.4M
-33,018
Closed -$338K
VMEO
527
DELISTED
Vimeo
VMEO
-30,793
Closed -$197K
VST icon
528
Vistra
VST
$50.4B
-3,202
Closed -$441K
WEN icon
529
Wendy's
WEN
$1.44B
-32,507
Closed -$530K
WGS icon
530
GeneDx Holdings
WGS
$1.89B
-3,910
Closed -$301K
WM icon
531
Waste Management
WM
$96.4B
-3,338
Closed -$674K
WOLF icon
532
Wolfspeed
WOLF
$1.12B
-10,762
Closed -$71.7K
WPC icon
533
W.P. Carey
WPC
$17B
-3,911
Closed -$213K
WSBC icon
534
WesBanco
WSBC
$4.02B
-11,530
Closed -$375K
WU icon
535
Western Union
WU
$2.6B
-12,861
Closed -$136K
XEL icon
536
Xcel Energy
XEL
$50.7B
-5,820
Closed -$393K
XP icon
537
XP
XP
$8.74B
-41,042
Closed -$486K
ZBH icon
538
Zimmer Biomet
ZBH
$18.6B
-1,977
Closed -$209K
ZIP icon
539
ZipRecruiter
ZIP
$369M
-26,328
Closed -$191K
ASTH icon
540
Astrana Health
ASTH
$1.89B
-6,695
Closed -$211K
ALAB icon
541
Astera Labs
ALAB
$44.5B
-2,758
Closed -$365K
RDDT icon
542
Reddit
RDDT
$34.4B
-1,516
Closed -$248K
VIK icon
543
Viking Holdings
VIK
$46.4B
-6,369
Closed -$281K
LOGC
544
DELISTED
ContextLogic
LOGC
-26,330
Closed -$185K
NARI
545
DELISTED
Inari Medical, Inc. Common Stock
NARI
-4,062
Closed -$207K

Similar funds

PharVision Advisers's Q1 2025 Portfolio in Review

As of Q1 2025, PharVision Advisers held 545 positions worth $72.1M, down 39% from $118M the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.

PharVision Advisers withdrew a net $42.5M in Q1 2025, closing 286 positions and reducing 47 holdings. Its most notable exit was CSG Systems International, an estimated $888K position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

Against the trend, PharVision Advisers opened a new position in Navigator Holdings worth $609K.

  • PharVision Advisers's largest Q1 2025 buy was Navigator Holdings: 45,751 shares worth $609K.
  • PharVision Advisers added most to Autodesk in Q1 2025, an estimated $406K increase.
  • PharVision Advisers's biggest Q1 2025 reduction was Meta Platforms (Facebook), cutting an estimated $701K.
  • PharVision Advisers fully exited CSG Systems International in Q1 2025, selling an estimated $888K.
  • PharVision Advisers's ten largest holdings make up 8.5% of its $72.1M portfolio in Q1 2025.
  • PharVision Advisers opened 165 new positions and closed 286 in Q1 2025.
  • PharVision Advisers's portfolio value fell 39% quarter-over-quarter to $72.1M.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.